In the current adverse macro environment, identifying reliable dividend stocks to buy may provide long-term financial stability and constant income. Dividend stocks offer a dual advantage.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Clorox (CLX) benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Super Micro Computer has proven to be an AI winner. Clorox looks ready for a rebound.
Nine long-term dividend growth companies announced their annual dividend increases in June. Investors in convenience store chain Casey's, grocer Kroger's, and health insurer UnitedHealth were rewarded with 10%+ income boosts. July brings increases from another 17 long-term dividend growth companies including Clorox, Altria, and Duke Energy.
Clorox is poised for revenue and margin growth recovery after the cyberattack last August, with market share nearly regained and focus shifting to product innovation and advertising. The company benefits from operating leverage, improved product mix, and moderating input costs, supporting margin expansion and a positive growth outlook. Valued below historical averages with a 3.51% dividend yield, Clorox presents a buying opportunity given its strong growth potential and anticipated upward revision in estimates.
Buying Union Pacific stock is a great way to pick up dividends over the long term. UPS stock is down, but that just means there's a great opportunity for patient investors.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Clorox (CLX) benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Clorox overestimated changes in consumer behavior trends. The company needs to prove higher expenses are worth it.